3 3:@0.498743:0.961646:0.503401:0.959948:0.503401:0.943683:0.498743:0.945381:0.008399:-0.012141:-0.418572
百靈佳殷格翰:@0.449093:0.047478:0.549886:0.047478:0.549886:0.035100:0.449093:0.035100:0.016799:0.016799:0.016799:0.016799:0.016799:0.016799
價 值:@0.348809:0.174300:0.651190:0.174300:0.651190:0.085177:0.348809:0.085177:0.120952:0.060476:0.120952
從合作中誕生:@0.358889:0.213850:0.641111:0.213850:0.641111:0.184143:0.358889:0.184143:0.048381:0.048381:0.048381:0.048381:0.048381:0.040317
科研製藥公司百靈佳殷格翰現在比以往更注重合作關係的多元性。因此，公:@0.131905:0.326479:0.928476:0.326479:0.928476:0.309150:0.131905:0.309150:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.023519:0.024201:0.024201:0.023519:0.024201:0.023519
司內部緊密的合作網，以及與外部合作夥伴的交流合作同樣重要。:@0.071439:0.356806:0.753475:0.356806:0.753475:0.339476:0.071439:0.339476:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519
百靈佳殷格翰躋身全球前二十大領先的製藥公司。我們的總公司位於德國殷格:@0.131914:0.417459:0.928580:0.417459:0.928580:0.400129:0.131914:0.400129:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.020555:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519
翰，但業務遍及全球各地，目前員工人數約五萬人。百靈佳殷格翰成立於一八八五:@0.071439:0.447785:0.928641:0.447785:0.928641:0.430456:0.071439:0.430456:0.023519:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023519:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023519:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023519
年，以家族企業出發，全心全力投入研究、開發、製造及行銷有高度療效的新藥與:@0.071439:0.478112:0.928312:0.478112:0.928312:0.460782:0.071439:0.460782:0.023519:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023519:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023519:0.023848:0.023848:0.023519:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023519
疫苗，造福人類及動物。:@0.071439:0.508438:0.330142:0.508438:0.330142:0.491109:0.071439:0.491109:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519
肩負起社會責任是百靈佳殷格翰重要的企業文化要素，包括在全球推行「開:@0.131914:0.569091:0.928486:0.569091:0.928486:0.551762:0.131914:0.551762:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.023519:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.024201:0.023519:0.024201:0.023519
創健康」等社會公益項目，與諸多員工關懷計畫。而尊重員工、機會平等、兼顧工:@0.071439:0.599418:0.928312:0.599418:0.928312:0.582089:0.071439:0.582089:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023519:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023848:0.023519:0.023848:0.023848:0.023848:0.023848:0.023848:0.023519:0.023848:0.023848:0.023848:0.023848:0.023519:0.023848:0.023848:0.023848:0.023519
作與個人生活正是團結合作理念的基礎。同時，我們也時時關注環保與永續發展。:@0.071439:0.629744:0.918105:0.629744:0.918105:0.612415:0.071439:0.612415:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519
2016 年百靈佳殷格翰全球的銷售淨額高達約一百五十九億歐元，並投入其中:@0.131914:0.690398:0.928354:0.690398:0.928354:0.673068:0.131914:0.673068:0.011759:0.011759:0.011759:0.011759:0.006007:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.024012:0.023519:0.024012:0.024012:0.024012:0.024012:0.024012:0.023519
百分之十九點六作為研發新藥疫苗的費用。:@0.071439:0.720724:0.518290:0.720724:0.518290:0.703395:0.071439:0.703395:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519:0.023519
百靈佳殷格翰:@0.449090:0.047479:0.549884:0.047479:0.549884:0.035101:0.449090:0.035101:0.016799:0.016799:0.016799:0.016799:0.016799:0.016799